Category Specific RSS

i-body

AdAlta secures second Japanese patent for its antibody candidate AD-214

The Covid vaccine functioned by introducing the virus into our bodies, thus encouraging them to build antibodies. It was the…

3 years ago

AdAlta approved to commence clinical trials with sniper protein

Innovative biotech company AdAlta (ASX: 1AD) has been approved to commence human clinical trials for its next generation of protein…

5 years ago